Colton Groome Financial Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-767
Closed -$239K 140
2025
Q2
$239K Buy
+767
New +$293K 0.08% 117
2025
Q1
Sell
-487
Closed -$246K 134
2024
Q4
$246K Buy
487
+87
+22% +$49.4K 0.09% 114
2024
Q3
$234K Hold
400
0.09% 120
2024
Q2
$204K Sell
400
-72
-15% -$35.3K 0.08% 122
2024
Q1
$233K Sell
472
-145
-24% -$73.7K 0.09% 106
2023
Q4
$325K Buy
617
+52
+9% +$27.7K 0.14% 89
2023
Q3
$285K Sell
565
-1,547
-73% -$761K 0.14% 95
2023
Q2
$1.02M Buy
2,112
+244
+13% +$119K 0.48% 49
2023
Q1
$883K Buy
1,868
+794
+74% +$383K 0.42% 51
2022
Q4
$569K Buy
1,074
+236
+28% +$125K 0.28% 62
2022
Q3
$423K Buy
838
+15
+2% +$7.89K 0.22% 64
2022
Q2
$423K Buy
823
+100
+14% +$50.2K 0.21% 59
2022
Q1
$369K Sell
723
-980
-58% -$473K 0.17% 70
2021
Q4
$855K Buy
1,703
+58
+4% +$26.3K 0.35% 57
2021
Q3
$643K Hold
1,645
0.28% 57
2021
Q2
$659K Buy
+1,645
New +$656K 0.3% 55

Other funds holding UNH

Colton Groome Financial Advisors's UNH Position: Q3 2025 in Review

Colton Groome Financial Advisors sold out of UnitedHealth (UNH) in Q3 2025, closing a stake of 767 shares — an estimated $239K sold.

Colton Groome Financial Advisors first reported a position in UNH in Q2 2021 and held it in 16 quarters. The position peaked at $1.02M in Q2 2023. 3,159 funds tracked by Wall St. Rank hold UNH as of Q3 2025.

  • Colton Groome Financial Advisors reported no remaining UnitedHealth position as of Q3 2025 after selling out during the quarter.
  • Colton Groome Financial Advisors sold 767 UnitedHealth shares in Q3 2025, an estimated $239K.
  • Colton Groome Financial Advisors first reported a position in UnitedHealth in Q2 2021 and held it in 16 quarters.
  • Colton Groome Financial Advisors's UnitedHealth position peaked at $1.02M in Q2 2023.
  • 3,159 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2025.

Based on Colton Groome Financial Advisors's 13F filing for Q3 2025, filed 30 Oct 2025.